(Q47707104)

5 February 2018

title

Investigating the candidacy of a lipoteichoic acid-based glycoconjugate as a vaccine to combat Clostridium difficile infection. (English)

1 reference

5 February 2018

main subject

Clostridium difficile

0 references

author name string

Andrew D Cox

1

1 reference

5 February 2018

Frank St Michael

2

1 reference

5 February 2018

Annie Aubry

3

1 reference

5 February 2018

Chantelle M Cairns

4

1 reference

5 February 2018

Philippa C R Strong

5

1 reference

5 February 2018

Alexander C Hayes

6

1 reference

5 February 2018

Susan M Logan

7

1 reference

5 February 2018

publication date

23 August 2013

1 reference

5 February 2018

published in

Glycoconjugate Journal

1 reference

5 February 2018

volume

30

1 reference

5 February 2018

issue

9

1 reference

5 February 2018

page(s)

843-855

1 reference

5 February 2018

https://scigraph.springernature.com/pub.10.1007/s10719-013-9489-3

exact match

0 references

cites work

Clostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistance

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9489-3

The epidemiology of community-acquired Clostridium difficile infection: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9489-3

Measures to control and prevent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9489-3

Treatment with monoclonal antibodies against Clostridium difficile toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9489-3

Neutralization of Clostridium difficile toxin A with single-domain antibodies targeting the cell receptor binding domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9489-3

The host immune response to Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9489-3

A novel fusion protein containing the receptor binding domains of C. difficile toxin A and toxin B elicits protective immunity against lethal toxin and spore challenge in preclinical efficacy models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9489-3

Evaluation of an oral suspension of VP20621, spores of nontoxigenic Clostridium difficile strain M3, in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9489-3

Fecal microbiota transplantation for recurrent clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9489-3

Meningococcal glycoconjugate vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9489-3

Carbohydrate-based Clostridium difficile vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9489-3

A possible oligosaccharide-conjugate vaccine candidate for Clostridium difficile is antigenic and immunogenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9489-3

Immunological evaluation of a synthetic Clostridium difficile oligosaccharide conjugate vaccine candidate and identification of a minimal epitope.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9489-3

Structural characterization of surface glycans from Clostridium difficile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9489-3

Glycan arrays containing synthetic Clostridium difficile lipoteichoic acid oligomers as tools toward a carbohydrate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9489-3

Pseudomonas exotoxin contains a specific sequence at the carboxyl terminus that is required for cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9489-3

Structural analysis of the lipopolysaccharide from Neisseria meningitidis strain BZ157 galE: localisation of two phosphoethanolamine residues in the inner core oligosaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9489-3

Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: immunology of glycoconjugates with high carbohydrate loading

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9489-3

Investigating the potential of conserved inner core oligosaccharide regions of Moraxella catarrhalis lipopolysaccharide as vaccine antigens: accessibility and functional activity of monoclonal antibodies and glycoconjugate derived sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9489-3

Immunological analysis of the EDTA-soluble antigens of Clostridium difficile and related species

21 January 2018

1 reference

12 December 2020

Immunochemistry of the cell-surface carbohydrate antigens of Clostridium difficile

1 reference

12 December 2020

Clostridium difficile cell-surface polysaccharides composed of pentaglycosyl and hexaglycosyl phosphate repeating units

1 reference

12 December 2020

Phosphorylation of the synthetic hexasaccharide repeating unit is essential for the induction of antibodies to Clostridium difficile PSII cell wall polysaccharide

1 reference

12 December 2020

In vitro and in vivo characterization of CB-183,315, a novel lipopeptide antibiotic for treatment of Clostridium difficile

1 reference

12 December 2020

Investigating the candidacy of lipopolysaccharide-based glycoconjugates as vaccines to combat Mannheimia haemolytica

1 reference

12 December 2020

First synthesis of C. difficile PS-II cell wall polysaccharide repeating unit

1 reference

12 December 2020

10.1007/S10719-013-9489-3

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

23974722

1 reference

5 February 2018